Lv1
20 积分 2022-10-24 加入
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
3天前
已完结
Rapid and High-Yielding Disulfide Bioconjugation at Any Desired Site in Proteins
20天前
已完结
Current Targets and Future Directions of Positive Inotropes for Heart Failure
25天前
已完结
Global epidemiology of heart failure
27天前
已完结
A novel approach to exploit Small-Molecule glucagon-like Peptide-1 receptor agonists with high potency
27天前
已完结
Discovery of Novel 5,6-Dihydro-1,2,4-triazine Derivatives as Efficacious Glucagon-Like Peptide-1 Receptor Agonists
27天前
已完结
A Trial of an Antibody–Oligonucleotide Conjugate
1个月前
已完结
An updated patent review of GLP-1 receptor agonists (2020-present)
1个月前
已完结
The therapeutic potential of phosphodiesterase 9 (PDE9) inhibitors: a patent review (2018-present)
2个月前
已完结
皖公网安备34019202002308
